Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$869,428
+$63,329 QoQ
Shares Held
15,089
+13.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,249
of 2,514 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. BMY ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,161 | $399,360 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $869,428 | 15,089 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $806,099 | 13,291 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $673,548 | 12,487 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $499,708 | 11,080 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $531,918 | 11,491 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $512,072 | 8,396 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $484,888 | 8,573 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $347,382 | 6,714 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $240,043 | 5,780 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $240,455 | 4,434 | Shares | Sole | 2024-04-24 | |
| 2023-09-30 | $1,277,866 | 22,017 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $4,465,948 | 69,835 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $6,575,370 | 94,869 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $7,107,292 | 98,781 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $6,877,317 | 96,741 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,618,766 | 85,958 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $6,038,485 | 82,685 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $4,886,930 | 78,379 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $6,401,720 | 108,192 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $6,900,568 | 103,271 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,725,638 | 90,696 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $4,280,070 | 69,000 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,998,131 | 33,142 | Shares | Sole | 2020-10-26 | |
| No filing history on record for this holder in this stock. | ||||||